Search Tag: Hologic

Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System

2017 03 Feb

--Smaller 6 mm Diameter and Product Updates Are Designed to Enhance Patient Comfort and Improve Physician Ease-of-Use-- Hologic, Inc. has announced the launch of its next-generation NovaSure® ADVANCED global endometrial ablation (GEA) system in  the United States . The system has been FDA approved. The NovaSure system is designed to reduce... Read more

Hologic Completes Divestiture of Blood Screening Business

2017 02 Feb

- Strengthens Efforts to Build a Sustainable Growth Company - - Accelerates Top- and Bottom-Line Growth Rates, Increases Financial Flexibility - Hologic, Inc. has completed the divestiture of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) for a purchase price of $1.85 billion in cash,... Read more

Hologic Appoints President of EMEA and Canada, Completing International Leadership Team

2017 09 Jan

Hologic, Inc. (Nasdaq: HOLX) has announced that Jan Verstreken has been named Regional President for  Europe ,  Middle East  and  Africa  (EMEA) and  Canada .  Mr. Verstreken's appointment completes Hologic's international sales leadership team, which includes  Sanjay Prabhakaran , Regional President for  Asia Pacific , and  Fernando Davico , General... Read more

Hologic to Announce Financial Results for the First Quarter of Fiscal 2017

2017 08 Jan

Hologic, Inc. has announced that the Company plans to release its financial results for the first quarter of fiscal 2017 on Wednesday, February 1, 2017, after the market closes.   In conjunction with the release, management will host a conference call that day at  4:30 p.m. Eastern Time . Interested participants may listen to the call by dialing... Read more

FDA Grants PMA Approval for Hologic's Aptima® HIV-1 Quant Assay

2017 03 Jan

--High-performing HIV viral load test now available alongside broad women's health menu on the fully automated Panther® system-- Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted PMA approval for the Company's HIV-1 viral load monitoring assay. The Aptima® HIV-1 Quant assay is a nucleic acid amplification... Read more

Hologic to Present at the 35th Annual J.P. Morgan Healthcare Conference

2016 21 Dec

Hologic, Inc. announced that the Company will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2017 at 10:30 a.m. Pacific Time. The presentation will be webcast live and may be accessed through a link on the investors section of Hologic's website at .  The webcast will be... Read more

Amy Wendell Elected to Hologic Board of Directors

2016 16 Dec

Hologic, Inc. (Nasdaq: HOLX) announced that  Amy Wendell  has been elected to the Company's Board of Directors, effective December 14. Ms. Wendell also was appointed to the Company's Audit and Finance Committee. Ms. Wendell brings to Hologic a wealth of experience in the healthcare industry, particularly in the areas of market and technology development. ... Read more

Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion

2016 15 Dec

- Transaction Strengthens Hologic's Efforts to Build a Sustainable Growth Company - - Deal Accelerates Company's Top- and Bottom-Line Growth Rates, Increases Financial Flexibility - Hologic, Inc. has entered into a definitive agreement to sell its share of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P... Read more

Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA

2016 27 Nov

--New products spotlight Hologic's leading tomosynthesis technology, including the world's first dedicated prone biopsy system with 2D or 3D™ imaging-- Hologic, Inc. will highlight its portfolio of innovative, award-winning breast cancer screening and interventional products, including the new Affirm™ prone breast biopsy system, at the 102nd Scientific... Read more

Hologic Announces Upcoming Put Option & Notice of Redemption

2016 10 Nov

Hologic, Inc. has announced that holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued  November 23, 2010  have the right to surrender their notes for repurchase by the Company.  This right is pursuant to the put option under the base indenture governing the notes dated  December 10, 2007 , as supplemented by... Read more